Opening book details…
About this Medicine article
THU0272 Epratuzumab Maintains Improvements in Disease Activity for Over 2 Years in Patients with Moderate-to-Severe Systemic Lupus Erythematosus: Results from an Open-Label Long-Term Extension Study (Sl0008) by Gordon, C.; Clowse, M.; Houssiau, F.; Petri, M.; Kilgallen, B.; Kalunian, K.; Strand, V.; Bongardt, S.; Wallace, D. J. is a Medicine article available to read on EtoBox.
It is typically read by researchers, students, and practitioners in Medicine.
- Author
- Gordon, C.; Clowse, M.; Houssiau, F.; Petri, M.; Kilgallen, B.; Kalunian, K.; Strand, V.; Bongardt, S.; Wallace, D. J.
- Publisher
- BMJ Publishing Group; BMJ (ISSN 0003-4967)
- Published
- 2013
- Language
- EN
- Field
- Medicine (Health Sciences)